Tim Dg Belderbos1, Hendrikus Jm Pullens1,2, Max Leenders1, Marguerite Ei Schipper3, Peter D Siersema1,4, Martijn Gh van Oijen1,5. 1. Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands. 2. Department of Gastroenterology and Hepatology, Meander Medical Center, Amersfoort, The Netherlands. 3. Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. 4. Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands. 5. Department of Medical Oncology, University of Amsterdam, Amsterdam, the Netherlands.
Abstract
BACKGROUND: Most post-colonoscopy colorectal cancers (PC-CRCs) are thought to develop from missed or incompletely resected adenomas. AIMS: We aimed to assess the incidence rate of PC-CRC overall and per colorectal segment, as a proxy for PC-CRC due to incomplete adenoma resection, and to identify adenoma characteristics associated with these PC-CRCs. METHODS: We performed a nationwide, population-based cohort study, including all patients with a first colorectal adenoma between 2000-2010 in the Dutch Pathology Registry (PALGA). Outcomes were the incidence rate of PC-CRC overall and of PC-CRC in the same colorectal segment, occurring between six months and five years after adenoma resection. A multivariable Cox proportional hazard analysis was performed to identify factors associated with PC-CRCs in the same segment. RESULTS: We included 107,744 patients (mean age 63.4 years; 53.6% male). PC-CRC was detected in 1031 patients (0.96%) with an incidence rate of 1.88 per 1000 person years. PC-CRC in the same segment was found in 323 of 133,519 adenomas (0.24%) with an incidence rate of 0.56 per 1000 years of follow-up. High-grade dysplasia (hazard ratio (HR) 2.54, 95% confidence interval (CI) 1.99-3.25) and both villous (HR 2.63, 95% CI 1.79-3.87) and tubulovillous histology (HR 1.80, 95% CI 1.43-2.27) were risk factors for PC-CRC in the same segment. CONCLUSIONS: Approximately one-third of PC-CRCs are found in the same colorectal segment after adenoma resection and could therefore be a consequence of incomplete adenoma resection, occurring in one in 400 adenomas. The risk of PC-CRC in the same segment is increased in adenomas with high-grade dysplasia or (tubulo)villous histology.
BACKGROUND: Most post-colonoscopy colorectal cancers (PC-CRCs) are thought to develop from missed or incompletely resected adenomas. AIMS: We aimed to assess the incidence rate of PC-CRC overall and per colorectal segment, as a proxy for PC-CRC due to incomplete adenoma resection, and to identify adenoma characteristics associated with these PC-CRCs. METHODS: We performed a nationwide, population-based cohort study, including all patients with a first colorectal adenoma between 2000-2010 in the Dutch Pathology Registry (PALGA). Outcomes were the incidence rate of PC-CRC overall and of PC-CRC in the same colorectal segment, occurring between six months and five years after adenoma resection. A multivariable Cox proportional hazard analysis was performed to identify factors associated with PC-CRCs in the same segment. RESULTS: We included 107,744 patients (mean age 63.4 years; 53.6% male). PC-CRC was detected in 1031 patients (0.96%) with an incidence rate of 1.88 per 1000 person years. PC-CRC in the same segment was found in 323 of 133,519 adenomas (0.24%) with an incidence rate of 0.56 per 1000 years of follow-up. High-grade dysplasia (hazard ratio (HR) 2.54, 95% confidence interval (CI) 1.99-3.25) and both villous (HR 2.63, 95% CI 1.79-3.87) and tubulovillous histology (HR 1.80, 95% CI 1.43-2.27) were risk factors for PC-CRC in the same segment. CONCLUSIONS: Approximately one-third of PC-CRCs are found in the same colorectal segment after adenoma resection and could therefore be a consequence of incomplete adenoma resection, occurring in one in 400 adenomas. The risk of PC-CRC in the same segment is increased in adenomas with high-grade dysplasia or (tubulo)villous histology.
Authors: Alan Moss; Stephen J Williams; Luke F Hourigan; Gregor Brown; William Tam; Rajvinder Singh; Simon Zanati; Nicholas G Burgess; Rebecca Sonson; Karen Byth; Michael J Bourke Journal: Gut Date: 2014-07-01 Impact factor: 23.059
Authors: Douglas J Robertson; E Robert Greenberg; Michael Beach; Robert S Sandler; Dennis Ahnen; Robert W Haile; Carol A Burke; Dale C Snover; Robert S Bresalier; Gail McKeown-Eyssen; Jack S Mandel; John H Bond; Rosalind U Van Stolk; Robert W Summers; Richard Rothstein; Timothy R Church; Bernard F Cole; Tim Byers; Leila Mott; John A Baron Journal: Gastroenterology Date: 2005-07 Impact factor: 22.682
Authors: Brian Bressler; Lawrence F Paszat; Zhongliang Chen; Deanna M Rothwell; Chris Vinden; Linda Rabeneck Journal: Gastroenterology Date: 2007-01 Impact factor: 22.682
Authors: Sidney J Winawer; Ann G Zauber; Robert H Fletcher; Jonathon S Stillman; Michael J O'Brien; Bernard Levin; Robert A Smith; David A Lieberman; Randall W Burt; Theodore R Levin; John H Bond; Durado Brooks; Tim Byers; Neil Hyman; Lynne Kirk; Alan Thorson; Clifford Simmang; David Johnson; Douglas K Rex Journal: Gastroenterology Date: 2006-05 Impact factor: 22.682
Authors: Rune Erichsen; John A Baron; Elena M Stoffel; Søren Laurberg; Robert S Sandler; Henrik Toft Sørensen Journal: Am J Gastroenterol Date: 2013-06-18 Impact factor: 10.864
Authors: S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish Journal: N Engl J Med Date: 1993-12-30 Impact factor: 91.245
Authors: Juan Francisco Ortega-Morán; Águeda Azpeitia; Luisa F Sánchez-Peralta; Luis Bote-Curiel; Blas Pagador; Virginia Cabezón; Cristina L Saratxaga; Francisco M Sánchez-Margallo Journal: BMC Cancer Date: 2021-04-26 Impact factor: 4.430
Authors: Theodore A Tollivoro; Christopher D Jensen; Amy R Marks; Wei K Zhao; Joanne E Schottinger; Virginia P Quinn; Nirupa R Ghai; Ann G Zauber; Chyke A Doubeni; Theodore R Levin; Bruce Fireman; Charles P Quesenberry; Douglas A Corley Journal: Gastrointest Endosc Date: 2018-08-23 Impact factor: 9.427